Lumpectomy vs. Mastectomy: Finding the Surgery That Feels Right for You

The moment someone says, “You need breast surgery,” your world can tilt. Suddenly, you’re weighing words you may never have thought much about before—lumpectomy, mastectomy—and trying to make a decision that feels enormous and deeply personal.
A lumpectomy removes the cancer while preserving as much of the breast as possible. A mastectomy removes the entire breast. Both are valid, effective options in different situations. This piece is here to help you understand how lumpectomy fits into breast cancer care today, so you can walk into your appointments feeling a little less alone and a lot more informed.

What Is a Lumpectomy?

A lumpectomy is often called breast-conserving surgery. The goal is to remove the tumor along with a small rim of surrounding tissue—called a margin—while keeping the rest of the breast intact.
Most women who have a lumpectomy will also receive radiation therapy afterward. Radiation helps treat any microscopic cancer cells that may still be present in the breast.
For many early-stage breast cancers, lumpectomy followed by radiation has been shown to offer outcomes similar to mastectomy. For many women, this option feels meaningful because it allows them to treat the cancer while staying connected to their body and sense of self.
If you want a deeper look at what lumpectomy involves, you can explore the full Lumpectomy Guide on Learn Look Locate.

What Is a Mastectomy?

A mastectomy removes the entire breast and, in some cases, additional nearby tissue depending on the surgical approach and whether reconstruction is planned.
Some women also choose to remove the other breast, particularly if they have a high-risk genetic mutation or strong family history—though this is not necessary or appropriate for everyone.
Your care team may lean toward mastectomy if the tumor is large relative to breast size, if there are multiple areas of cancer in the same breast, if you’ve already had radiation to that breast, or if certain genetic or medical factors are involved. Others choose mastectomy because it brings them greater emotional peace. Both paths are valid.

How Your Care Team Helps You Decide

This decision is not meant to be made alone. Your surgeon will usually consider factors such as:

• The size and location of your tumor relative to your breast size
• Whether the cancer is confined to one area or appears in multiple spots
• Tumor type and recommended additional treatments
• Whether radiation is safe and appropriate for you
• Your personal feelings about your body, scars, recovery, and peace of mind

The “right” choice is the one that aligns excellent cancer care with what feels livable and supportive for you—not anyone else’s expectations.

Why Lumpectomy Feels Right for Some Women

When lumpectomy is a safe option, many women choose it because it allows them to:

• Preserve their natural breast shape, which can feel grounding during a time of major change
• Know that outcomes can be similar to mastectomy for many early-stage cancers when radiation is part of the plan1
• Often experience a shorter surgery and gentler physical recovery compared with more extensive procedures
• Benefit from oncoplastic techniques, where the breast is reshaped during surgery to support both cancer control and appearance

Choosing lumpectomy is not “doing less.” It is choosing a thoughtful, effective treatment path that balances cancer removal with preserving as much of yourself as possible.

Why Mastectomy Feels Right for Others

For some women, keeping the breast feels more stressful than removing it. Personal history, family experiences, anxiety about recurrence, feelings about radiation, or concerns about needing multiple surgeries can all influence this choice.
You may hear many opinions—from friends, support groups, or online spaces—but your body, your history, and your comfort level are unique. There is no one “brave” or “correct” option here. There is only your choice.

How Innovative Technologies Support Lumpectomy

For years, surgeons have relied on imaging, experience, and pathology to help ensure that all cancer is removed during lumpectomy. Even with careful planning, tiny cancer cells can be difficult to see, and some women need a second surgery.
LumiSystem™ is one example of technology designed to provide surgeons with more real-time information in the operating room. After the main tumor is removed, the surgeon can use a specialized camera to scan the surgical cavity in the breast. Areas that “light up” may prompt a closer look and, in some cases, removal of additional tissue during the same operation.
LumiSystem does not replace standard lumpectomy or pathology. It is one of several tools some centers use to support precision during breast-conserving surgery.

Questions You Can Bring Into the Room

You don’t need perfect wording. A few gentle, practical questions can go a long way, such as:

• Am I a candidate for lumpectomy, and what factors influence that decision for me?
• How would recovery and next steps—like radiation—differ between lumpectomy and mastectomy?
• How often do your patients need a second surgery after a lumpectomy due to margins?
• Are oncoplastic techniques an option for me?
• Does this hospital use any real-time tools, like LumiSystem, during lumpectomy procedures?

Asking questions doesn’t make you difficult—it makes you informed and engaged in your care.

Where to Go Next

If you’re still weighing your options, the next step is to spend time with the full Lumpectomy Guide on Learn Look Locate. Created with breast surgical oncologist Dr. Barry Rosen, it explores candidacy, margins, surgical planning, recovery, and how novel technologies fit into today’s care.

FAQs: Lumpectomy vs. Mastectomy

Q1. Is lumpectomy as effective as mastectomy?
A: For many early-stage breast cancers, lumpectomy followed by radiation offers outcomes similar to mastectomy. Your care team will help you understand what applies to your specific diagnosis.

Q2. Will I always need radiation after a lumpectomy?
A: Most women do, though there are some exceptions. Radiation helps reduce the risk of cancer returning in the same breast.

Q3. Does choosing lumpectomy mean a higher risk of recurrence?
A: When combined with radiation and appropriate systemic treatments, lumpectomy can offer excellent long-term outcomes for many patients.

Q4. Why do some women choose mastectomy even if lumpectomy is an option?
A: Emotional comfort, family history, genetics, feelings about radiation, or a desire to avoid additional surgeries all play a role. These reasons are valid and personal.

Q5. Can reconstruction be done after a mastectomy?
A: Yes. Many women choose reconstruction, while others do not. Both choices are respected and supported.

Q6. Do newer technologies change the lumpectomy decision?
A: Some tools, like real-time imaging systems, may help surgeons assess tissue during surgery, but they are used alongside—not instead of—standard surgical planning and pathology.

Important Safety Information

What is LUMISIGHT (pegulicianine) and Lumicell DVS?

• LUMISIGHT (pegulicianine) is an optical imaging agent, and Lumicell DVS is a fluorescence imaging device. LUMISIGHT and Lumicell DVS, in combination, are used in adults with breast cancer to help detect any remaining cancerous tissue at the surgical site following removal of the primary specimen during a lumpectomy procedure.

What is the most important information to know about LUMISIGHT?

• Hypersensitivity Reactions: LUMISIGHT may cause serious hypersensitivity reactions, including anaphylaxis. Anaphylaxis has occurred in 4/726 (0.6%) of patients in clinical studies. Tell your doctor if you have any history of hypersensitivity reactions to pegulicianine or to contrast media or products containing polyethylene glycol (PEG). Your healthcare provider should have emergency resuscitation drugs, equipment, and trained personnel available during the use of LUMISIGHT. Healthcare providers should monitor all patients for hypersensitivity reactions, and if one is suspected, immediately discontinue the injection and initiate appropriate therapy.
• The most common side effects (≥1%) include hypersensitivity and an abnormal color in urine.

What additional important information should I know about LUMISIGHT and Lumicell DVS?

• Adjunctive Use: Lumicell DVS is for use as part of the lumpectomy procedure and is not a replacement for the standard of care lumpectomy procedure and pathology.
• Risk of Misdiagnosis: The absence of a signal in surgery does not rule out cancer. Additionally, a positive signal may be seen in noncancerous tissue.
• Interference from Dyes Used for Sentinel Lymph Node Mapping: Your healthcare provider should avoid the use of dyes before imaging the lumpectomy cavity in patients who have received LUMISIGHT.
• Other Risks: Using the Lumicell DVS handheld probe may cause tissue damage or infection.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088. Please see the LUMISIGHT Prescribing Information, including Boxed Warning, and Lumicell DVS Instructions for Use. For complete product information www.LumiSystem.com.

References

1. de Boniface J, Szulkin R, Johansson ALV. Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women. JAMA Surg. 2021;156(7):628–637. doi:10.1001/jamasurg.2021.1438